Sureshnee Pillay

Completed her MSc in 2014. Currently at Africa Centre for Health and Population Studies.

Contact Details:

Email: spillay@africacentre.ac.za

Telephone: +27 (0) 31 260 4654

Background

I am currently studying towards my Masters degree at the Africa Centre Virology Laboratory. My research involves investigating the virologic failure and the spectrum of drug resistance mutations in a paediatric ART programme in Rural KZN, SA. We used the open access Southern African Treatment Resistance Network (SATuRN) drug resistance genotyping system in this study to show that genotyping to assess resistance patterns and to guide treatment switches can be done affordably in resource limited settings such as ours.


Videos Videos Descriptions

YouTube Video

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Author: Manasa J, Danaviah S, Pillay S, Padayachee P, Mthiyane H, Seebregts C, Rinke De Wit TF, Viljoen J, Katzenstein D, De Oliveira T - Date: 2013-10-18

SATuRN/Life Technologies open access and affordable drug resistance genotyping system. This is a video that accompain a peer-reviewed manuscript that provides detailed information on how to our affordable drug resistance testing. The paper and video are open accessible!


Open access pdf Publications

HIV drug resistance levels in adults failing first-line antiretroviral therapy in an urban and a rural setting in South Africa.
Rossouw TM, Nieuwoudt M, Manasa J, Malherbe G, Lessells RJ, Pillay S, Danaviah S, Mahasha P, van Dyk G, de Oliveira T, HIV Med. (2016), 2016 :doi: 10.1111/hiv.12400.

Increasing HIV-1 drug resistance between 2010 and 2012 in adults participating in population-based HIV surveillance in rural KwaZulu-Natal South Africa.
Manasa J, Danaviah S, Lessells RJ, Elshareef M, Tanser F, Wilkinson E, Pillay S, Mthiyane H, Mwambi H, Pillay D, de Oliveira T, AIDS Res Hum Retroviruses (2016), 32(8):763-769.

Analysis of Dominant HIV Quasispecies Suggests Independent Viral Evolution Within Spinal Granulomas Coinfected with Mycobacterium tuberculosis and HIV-1 Subtype C.
Danaviah S, de Oliveira T, Gordon M, Govender S, Chelule P, Pillay S, Naicker T, Cassol S, Ndung'u T, AIDS Research and Human Retroviruses (2016), :doi:10.1089/aid.2015.0189.

Evidence of Long-Lived Founder Virus in Mother-to-Child HIV Transmission.
Danaviah S, de Oliveira T, Bland R, Viljoen J, Pillay S, Tuaillon E, Van de Perre P, Newell ML, PLoS One (2015), 10(3):e0120389.

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings.
Manasa J, Danaviah S, Pillay S, Padayachee P, Mthiyane H, Seebregts C, Rinke De Wit TF, Viljoen J, Katzenstein D, De Oliveira T , Journal of Visualized Experiments (JoVE) (2014), (85):e51242, doi:10.3791/51242.

Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort.
Pillay S, Bland RM, Lessells RJ, Manasa J, de Oliveira T, Danaviah S., AIDS Res Ther. (2014), 11(1):3. doi: 10.1186/1742-6405-11-3.

Dried Blood Spot HIV-1 RNA Quantification Using Open Real-Time Systems in South Africa and Burkina Faso.
Viljoen J, Gampini S, Danaviah S, Valea D, Pillay S, Kania D, Meda N, Newell ML, Van de Perre P, Rouet F; for the World Health Organization/ANRS 1289 Kesho Bora Study Group, Acquir Immune Defic Syndr (2010), 55(3):290-8.

bioafrica - News Section from Bioafrica and SATuRN websitesbioafrica - News Section from Bioafrica and SATuRN websitesbioafrica - News Section from Bioafrica and SATuRN websitesbioafrica - News Section from Bioafrica and SATuRN websitesbioafrica - News Section from Bioafrica and SATuRN websitesbioafrica - News Section from Bioafrica and SATuRN websitesbioafrica - News Section from Bioafrica and SATuRN websitesbioafrica - News Section from Bioafrica and SATuRN websitesbioafrica - News Section from Bioafrica and SATuRN websitesbioafrica - News Section from Bioafrica and SATuRN websites
News News Description and Link

bioafrica - News Section from Bioafrica and SATuRN websites

KRISP News

Even with easy access to ARVs, only one in three HIV-positive people will seek them

KRISP News - 2017-12-05

By Katharine Child, 05 December 2017. SA's policy to reduce HIV infections is to do what the UN recommends, which is to get 90% of people tested, 90% of HIV-positive people taking antiretrovirals and 90% of those on treatment taking it properly so they are not infectious. This will ultimately decrease the rate of new infections...


KRISP News

South Africans with HIV miss out on the benefits of early treatment due to a fear of stigma

KRISP News - 2017-12-02

By Linda Nordling, 2 December 2017, Quartz Africa. Antiretrovirals 'the drugs used to keep HIV in check' don't only prevent people from getting AIDS; they also keep virus levels low, making those taking them less likely to pass the infection to others.


KRISP News

KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP) Established

KRISP News - 2017-07-12

The Technology Innovation Agency (TIA) and UKZN have signed an agreement for the establishment of KRISP - the KwaZulu-Natal Research and Innovation Sequencing Platform.


SASBi & SAGS

4th Joint Congress of the South African Society for Bioinformatics (SASBi) and the South African Genetics Society (SAGS)

SASBi & SAGS - 2016-09-23

The biennial SASBi and SAGS congresses are the premier national scientific meetings on bioinformatics and genetics in South Africa. In total, 187 participats delivered 40 oral presentations and 65 posters in SASBi-SAGS-2016. This congress provided an exciting opportunity to learn about cutting-edge research in both disciplines, and to network with members of the two societies and with leading international scientists.


Science

South Africa's bid to end AIDS

Science - 2016-06-29

Science magazine (Vol. 353, Issue 6294, pp. 18-21, 2016). This issue was published before the AIDS conference in Durban 2016 and highlights some of our research, including our treatment as prevention trial (TasP) as well our phylogenetic analysis (de Oliveira et al. Lancet HIV 2016).


WTAC & MRC Flagship UKZN

Research travel grants: Doctoral or post-doctoral students to Wellcome Trust Africa Centre, South Africa

WTAC & MRC Flagship UKZN - 2015-08-15

Introduction: This is an excellent opportunity for outstanding and motivated individuals to access one of the most comprehensive population-based HIV surveillance and genomics datasets in the world at the Wellcome Trust Africa Centre for Health and Population Studies based in KwaZulu-Natal, South Africa.


SATuRN & AWACC

AWACC & SATuRN conference a success! Please see twitter summary

SATuRN & AWACC - 2014-10-13

SATuRN annual workshop run in partnership with AWACC (UKZN, NDoH & Harvard). In total 346 participants attended the two days workshop. The workshop discussions were also very good. Here, we summarize the Tweeter coverage of the event, which contains information on the topics discussed and questions raised.


SATuRN & Harvard

Doris Duke Annual Seminar for Medical Students from Harvard and UKZN

SATuRN & Harvard - 2014-10-09

Each year during AWAAC, the Doris Duke International Research Fellowship at Harvard Medical School sponsors a special seminar for medical students who will be attending the conference. During the seminar, invited faculty members discuss journals article that they select with a group of medical students from the US who are engaging in research in sub-Saharan Africa and a group of South African medical students from UKZN. This year 20-25 students will attend the seminar.


WT Africa Centre, UCL & LSHTM

Postdoctoral Research Fellows in HIV

WT Africa Centre, UCL & LSHTM - 2014-07-17

We invite applications from ambitious clinical or non-clinical postdoctoral scientists, to undertake research in a Flagship programme of the Wellcome Trust & MRC in South Africa


AIGHD

SATURN-PASER unites international minds & reveals potential resistance free HIV drug

AIGHD - 2013-11-26

By Inez Rossouw, 26 Nov 2013, Bloemfontein - Dolutegravir, a drug aimed against the human immunodeficiency virus (HIV), might not elicit any resistance to it. This was revealed at the Southern African HIV/TB drug resistance and monitoring workshop hosted by the Southern African Treatment and Resistance Network (SATuRN) at the Medical School of the University of the Free State.


Wellcome Trust

New Director named for leading HIV research centre in South Africa

Wellcome Trust - 2013-09-02

Deenan Pillay, Professor of Virology at UCL (University College London), is today named as the new Director of the Africa Centre for Health and Population Studies, one of the Wellcome Trust's major overseas programmes.



Page design updated by Tulio de Oliveira, 2015